Bio key international inc (BKYI)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'11Sep'11Jun'11Mar'11
Net loss

-1,829,567

-1,425,743

-1,803,508

-1,380,103

-1,641,316

-1,655,464

-2,191,992

475,963

-1,605,785

-1,789,329

-1,356,187

-516,579

-1,134,422

-1,375,489

-1,163,214

-606,767

-1,079,582

753,146

-924,103

-506,546

-51,526

-1,026,286

-299,214

-929,188

-782,554

-554,830

-315,579

-1,003,287

-540,165

-594,225

240,071

Allowance for doubtful accounts

-

-

-

-

-

-

-

0

0

0

500,000

500,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

19,814

20,611

19,292

15,534

24,487

23,576

21,020

19,183

18,013

7,694

7,819

11,274

13,187

13,059

11,518

10,947

10,779

10,664

10,606

10,281

9,889

9,758

10,258

10,267

6,751

5,864

5,736

8,496

8,202

8,150

6,614

Amortization of intangible assets

3,313

3,314

3,314

3,315

3,315

3,311

5,655

3,446

3,447

3,431

3,402

3,401

3,402

3,402

3,401

3,402

3,401

3,402

3,401

3,401

3,402

3,402

3,401

12,508

2,818

2,817

2,818

2,818

2,817

2,818

2,817

Amortization of resalable software license rights

281,137

281,076

281,074

-465,112

659,790

659,145

659,414

391,615

388,681

388,595

341,160

21,589

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

1,206

60,385

-49,468

-38

-11,086

27,975

-406

14,659

40,100

223,892

98,209

-204,948

-

-

-

-

-

-

-

-

Stock based directors fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

258,157

49,775

Amortization of capitalized contract costs

35,065

34,264

33,510

32,653

31,474

40,376

18,668

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

95,427

5,046

5,048

1,682

-

-

-

-

Stock based directors’ fees

6,501

5,506

16,505

7,002

7,509

6,509

16,512

4,005

18,017

5,005

5,003

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share and warrant-based compensation for employees and consultants

-

-

509,528

-

-

-

533,421

165,766

210,693

408,189

156,086

28,859

47,684

25,936

158,363

65,818

36,050

60,028

162,219

36,976

38,064

46,445

85,773

19,370

22,255

27,570

12,447

7,913

12,938

9,191

27,138

Stock based directors fees

-

-

-

-

-

-

-

-

-

-

-

118,001

9,000

23,999

16,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

83,434

-50,519

-833,613

920,509

161,872

166,475

-2,590,770

2,003,650

-285,593

285,418

-1,000,775

1,198,865

135,637

75,097

-1,167,758

1,219,248

2,031,431

-455,322

-36,034

-6,233

246,755

-961,142

1,061,936

188,174

-44,397

-308,862

-155,674

-40,608

2,047,157

-320,919

-1,063,377

Due from factor

-87,866

62,744

19,142

-23,719

52,738

-26,382

-55,820

81,115

-712

-88,429

64,253

49,597

1,718

-144,779

109,681

37,421

-1,542,184

1,658,232

-192,705

-

-

-

-

-

-

-135,755

-95,524

-

-

-

-

Operating leases right-of-use assets

-79,126

35,316

34,864

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capitalized contract costs

11,736

13,152

13,709

18,784

22,920

16,631

144,018

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in contract assets

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-40,536

30,795

-17,921

-45,324

113,675

31,318

-47,687

67,255

312,410

-3,773

105,527

77,192

88,197

21,186

110,208

197,925

-261,849

207,159

193,585

-200

-10,224

13,302

-429

3,696

-845

2,174

165

-12,016

6,933

1,604

1,941

Resalable software license rights

-5,814

-8,913

-26,130

-1,126,850

-8,568

-21,497

11,954

5,055

-3,959

-22,020

-53,628

450

-450

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other

21,219

-13,147

36,928

-22,086

16,202

-10,180

14,221

14,894

35,134

-29,727

13,171

70,269

43,553

-7,872

3,524

59,615

-36,632

-34,370

-127,839

155,843

6,395

-12,242

12,951

25,750

10,136

-21,707

34,215

-51,249

-179,435

12,781

87,908

Accounts payable

-510,835

401,699

124,534

111,484

39,354

77,446

-246,245

-8,656

174,259

179,935

-313,150

-83,965

-145,612

67,788

-529,924

-149,429

438,870

453,285

68,518

-109,967

105,216

28,220

-217,070

9,089

10,339

-217,824

-281,968

283,728

-93,933

206,897

110,336

Accrued liabilities

-235,709

136,254

29,764

-37,371

101,023

-40,102

-163,343

260,352

6,321

41,335

44,692

-1,745

-13,766

38,767

-181,001

60,274

-3,500

-35,123

-17,201

6,080

104,892

41,198

-1,874

-74,106

6,526

20,278

-207,976

113,916

-743

33,419

75,333

Due to factor

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-18,678

10,567

8,111

-

-

-

-

-

-

-

-

Deferred revenue

-71,540

-38,979

136,631

-59,129

-72,445

-46,256

-133,427

199,244

-108,842

-72,274

-143,324

392,908

-77,892

-137,245

78,886

-16,410

-208,936

143,517

29,001

-1,870

-74,621

-42,154

19,718

226,145

-73,694

-91,399

-41,412

-53,538

84,304

-120,041

331,693

Operating lease liabilities

80,913

-33,349

-32,897

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used for) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-661,588

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used for operating activities

-1,622,782

-416,927

160,496

-695,640

-1,016,811

-944,791

1,043,767

-661,051

-952,476

-968,888

116,953

-

-

-

-

-

-

13,626

-519,225

-806,110

-346,728

-73,460

-1,276,629

-919,459

-818,692

-338,326

-607,434

-150,081

158,889

-402,168

-129,751

Purchase of intangible assets

0

-1

1,737

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures

0

5,362

23,391

-30,083

13,664

35,622

32,857

-38,613

64,009

126,771

13,893

-1

1,193

32,496

19,287

1,286

0

2,078

0

9,280

3,852

1,702

3,799

-

-

-

-

0

3,400

0

52,804

Net cash used for investing activities

-512,821

-5,361

-25,128

-315

-13,664

-35,622

-32,857

-22,085

-64,009

-126,771

-13,893

-

-

-

-

-

-

-2,078

0

-9,280

-3,852

-1,702

-3,799

-

-

-

-

0

3,346,600

0

-52,804

Net cash used for investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-32,496

-19,287

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,697,100

1,050,000

0

902,693

-

-

-

-

Preferred dividends paid

-

-

-

-

-

-

-

-

-

-

-

0

200,624

200,625

133,851

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

125,209

Repayment of notes payable  related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

321,428

-

-

-

-

Proceeds from issuance of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

497,307

-

-

-

-

Repayment of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,112,135

500,000

Repurchase of outstanding warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

150,000

-

-

-

-

-

-

-

-

Costs to issue notes, common and preferred stock

-

-

-

-

-

-

-

0

0

74,420

5,946

52,246

1

915

31,704

400,616

4,907

32,671

20,908

-

-

-

-

433,548

95,957

0

46,176

-

-

-

-

Net cash used for financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-165,555

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing costs for note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

0

57,203

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

0

1,000,000

925,580

-5,946

-

-

-

-

-

-

-32,671

-20,908

1,491,843

0

0

-150,000

2,823,447

954,044

0

975,193

0

-3,350,000

237,865

-625,209

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

-608,783

227,712

135,368

-724,812

744,749

-995,625

1,010,910

-683,136

-16,485

-170,079

97,114

883,919

-1,829,277

-1,467,983

-846,430

4,248,846

-210,144

-21,123

-540,133

676,453

-350,580

-75,162

-1,430,428

1,798,021

125,755

-352,175

367,759

-150,081

155,489

-164,303

-807,764

Interest

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

100,000

0

0

0

-

-

-

-

-

-

51,494

0

-

0

80,286

0

Accrual of unpaid dividends on preferred stock

-

-

-

0

0

41,871

156,162

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of preferred dividends payable to common stock

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of preferred stock to common stock

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Dividends Payable on Series B-1 Preferred Stock to Common Stock [Member]
Conversion of preferred dividends payable to common stock

-

-

-

0

0

55,342

417,084

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Series B-1 Shares into Common Stock [Member]
Conversion of preferred stock to common stock

-

-

-

0

0

4,458,000

6,042,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounting Standards Update 2016-02 [Member]
Right-of-use asset addition under ASC 842

116,875

0

602,937

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities under ASC 842

116,875

0

590,342

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-